Imidazole derivatives as ccr2 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/06 (2006.01) A61K 31/4178 (2006.01) A61K 31/4439 (2006.01) A61P 9/00 (2006.01) C07D 401/14 (2006.01) C07D 403/06 (2006.01) C07D 405/14 (2006.01)

Patent

CA 2691662

The invention is concerned with novel imidazole derivatives of formula (I), wherein (Ia), m, E, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR- 2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.

L'invention concerne de nouveaux dérivés imidazolés de formule (I), dans laquelle m, E, R1, R2, R3, R4, R5, R6 et R7 sont tels que définis dans la description et dans les revendications, ainsi que des sels physiologiquement acceptables desdits dérivés. Ces composés sont des antagonistes du récepteur CCR-2, du récepteur CCR-5 et/ou du récepteur CCR-3 et peuvent être utilisés comme médicaments.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazole derivatives as ccr2 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazole derivatives as ccr2 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives as ccr2 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1862101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.